2025 PACC Miami | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting | A Real-World Evidence Review of the CAPLA 1000+ Project

2025 PACC Miami | Caplacizumab in the Immune-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Setting | A Real-World Evidence Review of the CAPLA 1000+ Project

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
Nov 23, 2025
Last Review
Nov 23, 2025
Expires
Nov 23, 2026

Objectives

NA

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE

Disclosure

<p></p>

Accreditation

NA